Which insiders are trading SCYNEXIS, Inc. (SCYX)?

SCYNEXIS, Inc. (NASDAQ:SCYX) is now up 15.79% compared to a 12-month low of $1.52. We have seen the price to move -8.81% lower and get settled at $1.76 on 11/08/2017. At recent session, it appeared stuck in a range of $1.72 to $1.93. This company shares are 439.77% off its target price of $9.5 and the current market capitalization stands at $47.47M. The recent change has given its price a -17.27% deficit over SMA 50 and -56.44% deficit over its 52-week high. The stock witnessed -21.78% declines, 11.39% gains and 3.53% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found SCYX’s volatility during a week at 7.13% and during a month it has been found around 6.93%.

SCYNEXIS, Inc. (SCYX) Top Holders

Institutional investors currently hold around $18 million or 39.2% in SCYX stock. Look at its top three institutional owners. Federated Investors Inc /Pa/ owns $8.12 million in SCYNEXIS, Inc., which represents roughly 17.11% of the company’s market cap and approximately 45.12% of the institutional ownership. Similar statistics are true for the second largest owner, Fmr Llc, which owns 932,173 shares of the stock are valued at $1.8 million. The third largest holder is Vanguard Group Inc, which currently holds $1.68 million worth of this stock and that ownership represents nearly 3.53% of its market capitalization.

SCYNEXIS, Inc. 13F Filings

At the end of 06/30/2017 reporting period, 19 institutional holders increased their position in SCYNEXIS, Inc. (NASDAQ:SCYX) by some 1,531,516 shares, 15 decreased positions by 3,636,889 and 8 held positions by 4,319,112. That puts total institutional holdings at 9,487,517 shares, according to SEC filings. The stock grabbed 8 new institutional investments totaling 434,695 shares while 7 institutional investors sold out their entire positions totaling 3,011,500 shares.

SCYNEXIS, Inc. (NASDAQ:SCYX) Insider Trades

Multiple company employees have indulged in significant insider trading. SCYNEXIS, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO Taglietti Marco has acquired 10,000 shares of SCYNEXIS, Inc. (SCYX) in trading session dated Sep. 22, 2017. These shares are worth $22,300 and were traded at $2.23 each. The SEC filing shows that Taglietti Marco performed a purchase of 5,000 shares. The CEO added these shares by way of transaction on Aug. 23, 2017. The company’s shares were assimilated at $1.85 per share worth to an investment of some $9,250 on account of Taglietti Marco.

CEO, Taglietti Marco, purchased 10,000 common shares of SCYNEXIS, Inc. (SCYX) in the open market. In a transaction dated Aug. 15, 2017, the shares were bought at an average price of $1.61, giving away a sum of $16,100. After this purchase, 287,000 common shares of SCYX are directly owned by the insider, with total stake valued at $505,120.

In the transaction dated Aug. 11, 2017, the great number of shares acquired came courtesy the Chief Medical Officer; Angulo Gonzalez David added a total of 10,000 shares at an average price of $1.55, amounting to approximately $15,500. The insider now directly owns 72,000 shares worth $126,720.

SCYNEXIS, Inc. (SCYX) Analyst Guide

Several analysts have released their opinion on SCYNEXIS, Inc. (NASDAQ:SCYX), with 3 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.6 average brokerage recommendation.

SHARE